2 Blue Chip Dividend Stocks That Are Top Buys in August
If you are looking for reliable dividend stocks that can provide steady income and growth in any market condition, you might want to consider these two blue chip companies that have proven their resilience and strength over time. Read on to find out more.
Abbott Laboratories (NYSE: ABT) is a global leader in healthcare products and services, with a diversified portfolio of medical devices, diagnostics, nutrition, and branded generic drugs. The company has a long history of innovation and excellence and has increased its dividend for 51 consecutive years.
In the second quarter of 2023, Abbott reported strong organic sales growth across three of its four operating segments, namely medical devices, established pharmaceuticals, and nutrition. During the quarter, the company benefited from the recovery in medical procedures after the pandemic-induced slowdown, the ongoing rebound in its infant formula business after last year's voluntary recall, and the robust demand for its continuous glucose monitoring franchise known as FreeStyle Libre.
Source Fool.com
Abbott Laboratories Aktie
Die Abbott Laboratories Aktie verzeichnet starke Buy-Einschätzungen ohne jegliche Sell-Einschätzungen.
Ein positives, wenn auch bescheidenes, Potenzial für Abbott Laboratories mit einem Kursziel von 115 € im Vergleich zum aktuellen Kurs von 100.52 €.
